Advertisement

Topics

Takeda and Molecular Templates Announce Multi-Target Research and...

10:23 EDT 3 Aug 2017 | Topix

The collaboration will apply Molecular Templates' engineered toxin bodies technology platform to potential therapeutic targets provided by Takeda through a joint scientific committee of both companies. "Over the past year, Takeda has expanded its collaborations in the Oncology space with the aim of accessing highly-innovative platforms to target specific tumor antigens using novel payloads and modality approaches," said Christopher Arendt, Ph.D., Head, Oncology DDU & Immunology Unit, Takeda.

Original Article: Takeda and Molecular Templates Announce Multi-Target Research and...

NEXT ARTICLE

More From BioPortfolio on "Takeda and Molecular Templates Announce Multi-Target Research and..."

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...